These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6487282)

  • 1. [Learning behavior in rats after chronic haloperidol treatment].
    Hoffmann W; Westermann KH
    Biomed Biochim Acta; 1984; 43(4):545-7. PubMed ID: 6487282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of raclopride and haloperidol on spontaneous motor activity and on conditioned avoidance behavior in rats. A comparison of potency, efficacy and time-course of action.
    Wadenberg ML; Ahlenius S
    Arzneimittelforschung; 1991 Jul; 41(7):692-5. PubMed ID: 1772455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuropharmacological activity of cerucal and haloperidol by intraperitoneal and intrastriatal administration in rats].
    Iakimovskiĭ AF
    Biull Eksp Biol Med; 1991 Dec; 112(12):602-4. PubMed ID: 1777621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of linear somatostatin on the active avoidance behaviour and open-field activity on haloperidol, phenoxybenzamine and atropine pretreated rats.
    Vécsei L; Bollók I; Telegdy G
    Acta Physiol Hung; 1983; 62(3-4):205-11. PubMed ID: 6141699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral supersensitivity to methamphetamine following chronic treatment with (--)-sulpiride in the rat.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):401-6. PubMed ID: 7195265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amphetamine and haloperidol on avoidance behavior and exploratory activity.
    Kovács GL; de Wied D
    Eur J Pharmacol; 1978 Dec; 53(1):103-7. PubMed ID: 738353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Locomotor activity of rats following chronic pretreatment with haloperidol].
    Oehler J; Westermann KH
    Acta Biol Med Ger; 1980; 39(11-12):1235-9. PubMed ID: 7245992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase inhibitors--are they potential neuroleptic drugs?
    Becker A; Grecksch G
    Behav Brain Res; 2008 Jan; 186(2):155-60. PubMed ID: 17854922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitation of active avoidance responding following chronic haloperidol treatment in rats.
    Rosic N; Overstreet DH
    Psychopharmacology (Berl); 1982; 78(2):135-6. PubMed ID: 6817369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term consequences of early experience on adult avoidance learning in female rats: role of the dopaminergic system.
    Schäble S; Poeggel G; Braun K; Gruss M
    Neurobiol Learn Mem; 2007 Jan; 87(1):109-22. PubMed ID: 16938473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central activity of 2-amino-4-phosphonobutyric acid (AP4).
    Zalewska A; Winnicka MM; Wiśniewski K
    Pol J Pharmacol; 1995; 47(1):9-17. PubMed ID: 7550555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Age related alterations of motor behavior and release of dopaminergic supersensitivity in rats].
    Westermann KH; Schmidt J
    Acta Biol Med Ger; 1981; 40(12):1737-43. PubMed ID: 6285650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice.
    Fukushiro DF; Carvalho Rde C; Ricardo VP; Alvarez Jdo N; Ribeiro LT; Frussa-Filho R
    Brain Res Bull; 2008 Sep; 77(2-3):124-8. PubMed ID: 18721669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery.
    Samaha AN; Reckless GE; Seeman P; Diwan M; Nobrega JN; Kapur S
    Biol Psychiatry; 2008 Jul; 64(2):145-52. PubMed ID: 18295747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative analysis of haloperidol effects on passive avoidance retention in aggressive and submissive mice].
    Dubrovina NI; Loskutova LV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2003; 53(2):165-9. PubMed ID: 12754842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Fundam Clin Pharmacol; 2007 Oct; 21(5):521-9. PubMed ID: 17868205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.